Clinical Trial Update: Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial assessing fluorouracil and oxaliplatin with or without panitumumab in high-risk, resectable colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• OXALIPLATIN (Oxaliplatin)
• Panitumumab (panitumumab)

Snippet

Sponsor: University of Birmingham | Conditions: Colorectal Cancer | Phase 2, Phase 3 | Status: UNKNOWN